Proposed Consensus Statement on Defining Psychedelic Drugs.
David E. Nichols, Charles D. Nichols, Peter S. Hendricks
Psychedelic Med (New Rochelle) March 13, 2023 DOI: 10.1089/psymed.2022.0008 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Keywords | Psychedelic drugs Psychedelics Hallucinogens Entheogens Psychoactive compounds Mind-altering substances Psychedelic compounds Drug definition Nomenclature Terminology Framework Consensus definition Standardization Drug classification Psychedelic definition Medical research Scientific study Drug development Clinical research Pharmacological research Therapeutic development Drug research Psychedelic research Drug action Pharmacodynamics Psychopharmacology Drug mechanisms Drug science Psychedelic pharmacology |
| Citations | 39 |
| Key points | Proposes that psychedelic drugs be defined by their primary mechanism of action (5-HT2A receptor agonism) and their characteristic effects on consciousness, perception, and cognition. |
Abstract
Proposed Consensus Statement on Defining Psychedelic Drugs.